AUD

Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders: A Systematic Review and Meta-Analysis

Jung Y, Montel RA, Shen P, Mash DC, Goldman D. Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders: A Systematic Review and Meta-analysis. JAMA Netw Open. 2019;2(11):e1914940. doi:https://doi.org/10.1001/jamanetworkopen.2019.14940
Publication Date

Key Points

Question: Is there a biological association between D2 dopamine receptor gene (DRD2) and alcohol use disorder?

Intelligence in Young Adulthood and Alcohol Use Disorders in a Prospective Cohort Study of Danish Men: The Role of Psychiatric Disorders and Parental Psychiatric History

Just-Østergaard E, Flensborg-Madsen T, Knop J, et al Intelligence in young adulthood and alcohol use disorders in a prospective cohort study of Danish men: the role of psychiatric disorders and parental psychiatric history BMJ Open 2019;9:e028997. doi: 10.1136/bmjopen-2019-028997
Publication Date

Abstract

Objectives: The aims were to estimate the association between intelligence measured in young adulthood and risk of alcohol use disorders (AUD) in men and to investigate the potential modification of this association by psychiatric disorders, parental AUD and parental psychiatric disorders.

Access to Care for People with Alcohol Use Disorder in France

Costa M, Marcellin F, Coste M, et al Access to care for people with alcohol use disorder in France: a mixed-method cross-sectional study protocol (ASIA) BMJ Open 2018;8:e024669. doi: 10.1136/bmjopen-2018-024669
Publication Date

Abstract

Introduction: Alcohol use disorder (AUD) is a major public health concern worldwide. In France, only 10% of people with AUD (PWAUD) receive medical care. General practitioners (GP) are one of the main entry points for AUD care.

The Hardest Hit: Addressing the Crisis in Alcohol Treatment Services

Published by
Alcohol Concern, Alcohol Research UK
Publication Date

This research, launched at the All Party Parliamentary Group on Alcohol Harm on 1 May 2018, warns that the alcohol treatment sector is in crisis. These services are entering into a cycle of disinvestment, staff depletion, and reduced capacity, and this is due to get worse; in 2020 ring-fenced public health funding will end, posing additional risk to the areas of highest need.

Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption

Gowin, J.L.; Sloan, M.E.; Stangl, B.L.; Vatsalya, V.; and Ramchandani, V.A. Vulnerability for alcohol use disorder and rate of alcohol consumption. The American Journal of Psychiatry 174(11):1094–1101, 2017. PMID: 28774194
Publication Date

"Binge drinking" may be more prevalent in individuals with an increased vulnerability to alcohol use disorder (AUD) and could act as an early warning indicator.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder

Published by
American Psychiatric Association
Publication Date

Rationale

The goal of this guideline is to improve the quality of care and treatment outcomes for patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric Association 2013).

More Treatments on Deck for Alcohol Use Disorder

Thirteen years have passed since the US Food and Drug Administration (FDA) last approved a new medication to help the nation’s millions of people with alcohol use disorder (AUD) stop or moderate their drinking. Only 3 such formulations exist, and 1, disulfiram, dates to the Prohibition era. Known commercially as Antabuse and introduced in 1923, it makes people memorably ill if they ingest alcohol, but it doesn’t stop the cravings. The other 2, naltrexone and